Established in 2001 and based in Puchheim, close-by Munich, Germany, Sloning BioTechnology is a protein engineering company and leading supplier of highly innovative synthetic biology tools.

Sloning’s superior combinatorial libraries are unbiased and enable researchers to increase the success rate of their screening for new and optimized therapeutic antibodies, proteins or industrial enzymes.

Key to Sloning’s success is the company’s core technology, Slonomics®, a proprietary fully automated genetic-engineering platform that utilizes sets of double stranded DNA triplets in the controlled fabrication of highly diverse combinatorial gene libraries.